INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
82
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed in U.S. District Court to Recover Losses Suffered by Investors in INSYS Therapeutics, Inc.

NEW YORK, April 26, 2017 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired shares of INSYS Therapeutics, Inc. (“INSYS”) (NASDAQ: INSY ) between February 23, 2016 and March 15, 2017 . You are hereby notified that Levi & Korsinsky has commenced the class action Erdmann v. INSYS Therapeutics, Inc.., et al. (Case No. 1:17-cv-02225) in the USDC for the Southern District of New York. Click here to view the complaint. To get more information go to :

http://www.zlk.com/pslra/insys-therapeutics-inc?wire=3

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) INSYS had overstated its 2015 net revenue; (2) INSYS had misstated its sales allowances for 2016; (3) accordingly, the Company lacked effective internal controls over financial reporting; and (4) as a result, INSYS public statements were materially false and misleading at all relevant times.

Take Action: if you suffered a loss in INSYS you have until May 16, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Orbis Celebrates 20 Years of Eye Care in Macau

Updated Category News Views 2

Celebrating Two Decades of Eye Health Innovation Orbis, a name synonymous with eye care worldwide, has hit a remarkable milestone. Celebrating two decades of commitment to eye health in Macau, they've rolled out their Flying Eye Hospital with a mission of profound impact. This isn't just about a fancy airplane; it’s about real, lasting change through training projects...

Continue Reading
Ramaco Resources Faces Stock Shake-Up Amid Distribution

Updated Category News Views 0

Stock Shake-Up In The Coal Industry Something's brewing in the coal mines of West Virginia, and it isn't just the usual dust settling. Ramaco Resources, Inc. (NASDAQ: METC), the metallurgical coal titan, is feeling the heat from some unexpected stock market turbulence, and it's got everyone in the investment trenches scratching their heads. The Yorktown Energy Partners'...

Continue Reading
What to Expect from KeyCorp at Barclays Event

Updated Category News Views 4

KeyCorp's Next Move: An Insider's View Yep, circle that calendar, folks. Looks like KeyCorp's gonna be laying it all out there for the financial world to see. Clark Khayat, their numero uno money guy, is hitting the stage at the Barclays Global Financial Services Conference on Sept. 14. So grab the popcorn—or, more like, your portfolio tracker—because this could get...

Continue Reading
Charity's Bold Move: Acquiring Wayfinder for K-12 Impact

Updated Category News Views 1

Public Charity Expands Into Education Well, here's something that's bound to turn a few heads: a fast-growing public charity has just made its first acquisition in the K-12 sphere by snapping up Wayfinder. The stakes are getting interesting. When a charity starts playing in the acquisition space, you're looking at a change in strategy that deserves close attention. Why...

Continue Reading
YSL Beauty’s Block Party Series Rocks London's Scene

Updated Category News Views 3

YSL Beauty: More Than a Brand, a Cultural Movement London felt a distinct pulse this past weekend as YSL Beauty kicked off another sizzling event in its Block Party series. This one wasn't just another Instagrammable gathering; it was the kind of scene that shifted the cultural needle. What started in Madrid has now become a roving spectacle that sweeps across cities,...

Continue Reading
XTEND Launches on NYSE Amid Market Milestones

Updated Category News Views 2

XTEND Steps Into the NYSE Spotlight Out of the gate, let's talk about XTEND—a name that's about to make waves on the New York Stock Exchange. With their debut under the ticker XTND, these folks are slamming their flag into the financial terrain like a knight ready for battle. XTEND, an AI-powered defense robotics and software outfit, isn't just joining the party—it's...

Continue Reading
Argo Biopharma's BW-20805 Shows Promise in HAE Phase II Trial

Updated Category News Views 1

Argo's Gains in Hereditary Angioedema Therapy Think about it, folks – reducing a hereditary angioedema attack by over 80%? Argo Biopharma, the slick operator in the RNA therapeutics space, is flexing its muscles again. They've hauled in some impressive data for their siRNA therapeutic, BW-20805, at the 2026 Bradykinin Symposium in Berlin. For you deep-pocketed investors...

Continue Reading
Ed Markey's Political Future on Shaky Ground in MA

Updated Category News Views 2

Massachusetts Voters Voice Desire for Change Ever seen an old engine stutter and cough before finally quitting? That's what Ed Markey's political career is starting to feel like. A fresh poll has surfaced, casting doubt over his steady grip on his longstanding Senate seat in Massachusetts. People are yearning for fresh faces and new ideas like never before. It's as if the...

Continue Reading
Acepodia's ACE723 Clears FDA Hurdle for Hepatocellular Push

Updated Category News Views 4

Unexpected Developments from Acepodia Folks keeping a keen eye on the biotech scene might just raise an eyebrow at Acepodia's latest move. The FDA has given their nod to ACE723, an ambitious dual-payload antibody-drug conjugate (ADC) designed to wrangle with those stubborn cases of unresectable or metastatic hepatocellular carcinoma (HCC). This isn't just another day in...

Continue Reading
Parents Champion Meta's Online Safety Agreement

Updated Category News Views 3

Any old-timer in the market game will tell you this: safeguarding the next generation runs deeper than just chasing profits. A recent poll by the Coalition to Empower our Future reveals something that ain’t too surprising if you’ve been paying attention. Parents all over the nation are nodding along to Meta’s new move to bolster online protections for younger folks....

Continue Reading

Top 5 Most Recently Viewed Articles

Hedge Fund Strategies: Insights for 2025 Market Dynamics

Updated Category News Views 2154

The Shifting Landscape of Hedge Fund Investments for 2025 As we navigate toward 2025, hedge fund investors are increasingly drawn to macro strategies, reflecting a transformative phase in the financial markets. This trend is largely driven by the evolving political landscapes and their potential impacts on economic conditions globally. Investors are strategically...

Continue Reading
EHang Secures Over $22 Million Investment from Enpower and Others

Updated Category News Views 128

EHang's Strategic Investment Boosts Urban Air Mobility Growth GUANGZHOU, China - EHang Holdings Limited (Nasdaq: EH), renowned for its leadership in Urban Air Mobility (UAM), has recently announced a significant strategic investment exceeding US$22 million. This investment is spearheaded by Zhuhai Enpower Electric Co., Ltd., a leading provider of power systems for new...

Continue Reading
e.l.f. Beauty, Inc. Class Action: Understand Your Rights

Updated Category News Views 123

e.l.f. Beauty, Inc. Class Action Overview Attention investors! A class action lawsuit has been filed against e.l.f. Beauty, Inc. This important case involves investors who purchased shares of this makeup brand during a specific time frame and may have experienced financial losses due to misleading information. Details of the Class Action Case e.l.f. Beauty, known for its...

Continue Reading
CareCloud Set to Lead AI Healthcare Discussion at Tech Event

Updated Category News Views 109

CareCloud to Showcase AI Innovations at Upcoming Tech Conference CareCloud, Inc. (Nasdaq: CCLD, CCLDO), known for its pioneering role in AI-driven healthcare technology solutions, is gearing up to take center stage at the upcoming virtual tech conference presented by Maxim Group LLC. This exciting event will feature an enlightening Healthcare IT Panel on June 3, where...

Continue Reading
Understanding Accenture's Short Interest Trends and Impacts

Updated Category News Views 216

Understanding Accenture's Short Interest Trends Accenture's short percent of float has notably dropped by 4.0% since its previous report. Currently, the company has approximately 6.03 million shares sold short, representing about 0.96% of all available regular shares for trading. This figure indicates that, with current trading volume, traders would require an estimated...

Continue Reading